Literature DB >> 8997394

In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat.

Y Liu1, E M Tolbert, A M Sun, L D Dworkin.   

Abstract

Renal hypertrophy develops early in the course of diabetes and has been linked to progressive renal disease. Although the mechanism of renal hypertrophy is unknown, evidence suggests that local alterations in the production of one or more growth factors and/or their receptors are crucial to this process. In this study, we demonstrate that the c-met protooncogene product, a tyrosine kinase receptor for hepatocyte growth factor (HGF), is increased in the kidney of the diabetic rat. Northern blot analysis showed that renal expression of the c-met gene was substantially increased in rats made diabetic by administration of streptozotocin. Immunohistochemical studies revealed that the protein for c-met was concordantly elevated in cortical and medullar tubular epithelium following the onset of diabetes. Moreover, in vitro studies demonstrated that short-term exposure to high glucose concentration markedly stimulated c-met expression in cultured proximal tubular (opossum kidney) and inner medulla collecting duct cells (mIMCD-3). The results of enhanced renal expression of c-met together with elevated HGF indicate that the HGF/c-met system is markedly activated in the diabetic rat. These findings suggest that the HGF/c-met system may play a role in the diabetic renal hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997394     DOI: 10.1152/ajprenal.1996.271.6.F1202

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Glomerular endothelial cell injury and cross talk in diabetic kidney disease.

Authors:  Jia Fu; Kyung Lee; Peter Y Chuang; Zhihong Liu; John Cijiang He
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-19

2.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

3.  Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology.

Authors:  Shuta Ishibe; Anil Karihaloo; Hong Ma; Junhui Zhang; Arnaud Marlier; Mitchihiro Mitobe; Akashi Togawa; Roland Schmitt; Jan Czyczk; Michael Kashgarian; David S Geller; Snorri S Thorgeirsson; Lloyd G Cantley
Journal:  Development       Date:  2009-01       Impact factor: 6.868

4.  HGF/C-MET PATHWAY HAS A ROLE IN TESTICULAR DAMAGE IN DIABETES INDUCED BY STREPTOZOTOCIN.

Authors:  M Gumustekin; A Arici; S Cilaker Micili; M Karaman; M E Guneli; I Tekmen
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

Review 5.  Growth factors and the development of diabetic nephropathy.

Authors:  Gunter Wolf
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

6.  Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis.

Authors:  Yingjian Li; Xiaoyan Wen; Youhua Liu
Journal:  Kidney Int       Date:  2012-01-25       Impact factor: 10.612

7.  Steap4 attenuates high glucose and S100B-induced effects in mesangial cells.

Authors:  Chao-Tang Chuang; Jinn-Yuh Guh; Chi-Yu Lu; Yeng-Tseng Wang; Hung-Chun Chen; Lea-Yea Chuang
Journal:  J Cell Mol Med       Date:  2015-03-27       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.